Cargando…
Strategic investments in non-communicable diseases (NCD) research in Africa: the GSK Africa NCD Open Lab
In March 2014, GSK announced a number of new strategic investments in Africa. One of these included investment of up to 25 million Pounds Sterling (£25 million) to create the world’s first R&D Open Lab to increase understanding of non-communicable diseases (NCDs) in Africa. The vision is to crea...
Autores principales: | Hall, Matthew D, Dufton, Ann M, Katso, Roy M, Williams, Pauline M, Gatsi, Sally A, Strange, Michael E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557486/ https://www.ncbi.nlm.nih.gov/pubmed/25962942 http://dx.doi.org/10.5830/CVJA-2015-042 |
Ejemplares similares
-
The investment case as a mechanism for addressing the NCD burden: Evaluating the NCD institutional context in Jamaica, and the return on investment of select interventions
por: Hutchinson, Brian, et al.
Publicado: (2019) -
Correction: The investment case as a mechanism for addressing the NCD burden: Evaluating the NCD institutional context in Jamaica, and the return on investment of select interventions
por: Hutchinson, Brian, et al.
Publicado: (2020) -
Correction: The investment case as a mechanism for addressing the NCD burden: Evaluating the NCD institutional context in Jamaica, and the return on investment of select interventions
Publicado: (2020) -
The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration
por: Aggarwal, Ajay, et al.
Publicado: (2020) -
JAPreventNCD
por: Klepp, K I
Publicado: (2023)